Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- AKYA
- Price
- -
- Stock movement up
- +- (0.00%)
- Company name
- Akoya Biosciences Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Medical Instruments & Supplies
- Market cap
- 64.44M
- Ent value
- 168.22M
- Price/Sales
- 0.74
- Price/Book
- 4.73
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return (CAGR)
- -44.16%
- 3 year return (CAGR)
- -54.37%
- 5 year return (CAGR)
- -
- 10 year return (CAGR)
- -
Last updated: 2025-09-12
DIVIDENDS
AKYA does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 0.74 |
| Price to Book | 4.73 |
| EV to Sales | 1.94 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 49.95M |
| EPS (TTM) | -1.17 |
| FCF per share (TTM) | -0.98 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 86.81M |
| Gross profit (TTM) | 48.23M |
| Operating income (TTM) | -45.29M |
| Net income (TTM) | -57.97M |
| EPS (TTM) | -1.17 |
| EPS (1y forward) | -0.56 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 55.56% |
| Operating margin (TTM) | -52.17% |
| Profit margin (TTM) | -66.77% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 12.56M |
| Net receivables | 12.79M |
| Total current assets | 76.86M |
| Goodwill | 18.26M |
| Intangible assets | 15.27M |
| Property, plant and equipment | 0.00 |
| Total assets | 129.97M |
| Accounts payable | 8.76M |
| Short/Current long term debt | 84.92M |
| Total current liabilities | 27.99M |
| Total liabilities | 116.34M |
| Shareholder's equity | 13.63M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -46.67M |
| Capital expenditures (TTM) | 2.01M |
| Free cash flow (TTM) | -48.68M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -425.20% |
| Return on Assets | -44.60% |
| Return on Invested Capital | -334.88% |
| Cash Return on Invested Capital | -281.22% |
STOCK INFORMATION
Downside potential
Loading...
Downside potential data
| AKYA | S&P500 | |
| Current price drop from All-time high | -95.05% | -0.26% |
| Highest price drop | -96.37% | -19.00% |
| Date of highest drop | 14 May 2025 | 8 Apr 2025 |
| Avg drop from high | -68.52% | -2.49% |
| Avg time to new high | 534 days | 6 days |
| Max time to new high | 1067 days | 89 days |
COMPANY DETAILS
Marketcap
64.44M
Marketcap category
Small-cap
Description
Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions for transforming discovery, clinical research, and diagnostics in North America, the Asia-Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or formalin-fixed paraffin-embedded tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers analysis software partnerships ecosystem; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. Akoya Biosciences, Inc. was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.
Employees
205
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner